ERBB2 and triple-negative breast carcinoma: Stem cells were isolated from non-tumoral breast epithelial cells of the MCF10A cell line, and the most representative and widely studied ER+, HER2 or triple negative breast cancer cell lines MCF7, SKBR3 and MDA-MB-231, respectively, as described in Methods.